| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 34.681 | 0 | 4 | 0 | 0 | 0 | 0 | 23.854 | 83.677 | 11.857 |
| Total Income - EUR | 37.863 | 0 | 442 | 46 | 1.475 | 148.201 | 0 | 26.186 | 83.677 | 19.040 |
| Total Expenses - EUR | 47.423 | 6.118 | 2.791 | 2.614 | 2.624 | 96.365 | 83 | 12.390 | 46.740 | 52.291 |
| Gross Profit/Loss - EUR | -9.560 | -6.118 | -2.349 | -2.568 | -1.148 | 51.836 | -83 | 13.796 | 36.937 | -33.250 |
| Net Profit/Loss - EUR | -9.560 | -6.118 | -2.349 | -2.568 | -1.148 | 47.835 | -83 | 13.518 | 36.184 | -33.250 |
| Employees | 4 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Uro Andromed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 123.706 | 122.392 | 118.128 | 113.744 | 113.714 | 17.720 | 17.327 | 24.018 | 99.617 | 80.401 |
| Current Assets | 5.842 | 739 | 850 | 422 | 163 | 15.922 | 15.292 | 24.603 | 19.908 | 22.509 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 882 | 448 | 357 | 74 | -45 | -44 | -43 | 4.711 | 19.227 | 22.241 |
| Cash | 4.960 | 290 | 493 | 348 | 208 | 15.966 | 15.335 | 19.892 | 681 | 268 |
| Shareholders Funds | -16.438 | -18.305 | -20.345 | -22.530 | -20.733 | 27.495 | 26.802 | 40.403 | 63.071 | 16.200 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 146.154 | 141.602 | 139.487 | 136.696 | 134.768 | 6.302 | 5.969 | 8.370 | 56.770 | 69.470 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17.465 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5520 - 5520" | |||||||||
| CAEN Financial Year |
5520
|
|||||||||
Comments - Uro Andromed Srl